On 2 October 2020, the Academy of Medical Sciences hosted a virtual roundtable on the role of academia and industry in the UK’s diagnostic testing response to COVID-19.
On the 26 February 2020, the Academy of Medical Sciences in partnership with the Japan Society for the Promotion of Science (JSPS) and Japan Agency for Medical Research and Development (AMED) held a symposium on Data-Driven Health: Data strategies to predict risk, prevent and manage disease in individuals and populations.
The Academy of Medical Sciences, the Thai Academy of Science and Technology, and Thailand’s National Center for Genetic Engineering and Biotechnology held a virtual policy workshop on antimalarial drug resistance in Southeast Asia on 28-29 October 2020.
The Academy of Medical Sciences, in collaboration with the Academia Nacional de Medicina del Perú and the Academia Nacional de Ciencias held a policy workshop on nutrition and anaemia in the Andean region on 20-21 January 2021.
The Academy has launched a rapid review exploring the challenges we might face this winter (2020/21) when coronavirus and other seasonal diseases are present, and how the UK can prepare for this.
The Academy of Medical Sciences in collaboration with 7 Academies and organisations from LMICs hosted a virtual workshop to consider the challenges of the COVID-19 pandemic and response in on 15– 18 June 2020. Watch the recording of final session including keynote presentation from Professor David Heymann, Dr Chikwe Ihekweazu, Dr Margaret Hamburg and Dr Moses Alobo here on our YouTube Channel.
In winter 2021, the Academy is calling for new project submissions to our COVID-19 preclinical drug development database.
We are mapping ongoing and emerging COVID-19 preclinical drug development research to help researchers and funders identify opportunities for collaboration, avoid duplication of effort and prioritise the most promising research.
Following the virtual meeting jointly hosted by the Brazilian National Academy of Medicine and the UK Academy of Medical Sciences to share learning from tackling the COVID-19 pandemic on the 16 April, the two Academy's have published a joint statement on COVID-19.
The Academy and the British Society for Immunology (BSI) have rapidly convened an expert group to collate what is currently known about the immunology of COVID-19 and develop Immunology research priorities in response to the coronavirus outbreak (COVID-19).
The Academy and MQ have endorsed the mental health and neuroscience research priorities in response to the coronavirus outbreak (COVID-19) that were developed by an expert group convened by the two organisations.